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We aimed to evaluate age-related cataract as a contributor to blindness and 
visual impairment (VI) in sub-Saharan Africa (SSA). 
Methods  
Systematic review of population-based studies published between 2000 and 
October 2012. Prevalence and proportions of blindness and VI due to 
cataract, cataract surgical coverage (CSC), % intraocular lens (IOL) 
implantation and visual outcomes of surgery in accordance with WHO criteria 
were ascertained.  
Results 
Data from 17 surveys (subjects mostly aged ≥50 years old) from 15 different 
countries in SSA were included, comprising 96,402 people.  Prevalence of 
blindness (presenting visual acuity<3/60 in better eye) ranged from 0.1% in 
Uganda to 9.0% in Eritrea, and the proportion of total blindness due to 
cataract ranged between 21 and 67%. Cataract was the principal cause of 
blindness and VI in 15 and 14 studies, respectively. There was a strong 
positive correlation between good visual outcomes and IOL use (R=0.69, 
P=0.027). Considerable inter-study heterogeneity was evident in CSC and 
visual outcomes following surgery, and between 40 and 100% of operations 
had used IOL’s.  
 
Conclusions 
Cataract represents the principal cause of blindness and VI and should 
remain a priority objective for eye care in SSA. However, the prevalence of 
blindness and VI due to cataract was variable and may reflect differences in 
the availability of cataract surgical programmes and cataract incidence. 
INTRODUCTION  
Cataract can manifest across one’s lifespan but its prevalence and incidence 
rise with increasing age. Age-related (or senile) cataract is the most common 
cause of cataract in adults. The burden of cataract is expected to continue to 
pose a greater challenge to health care systems worldwide in future years, 
consistent with population ageing and increases in life expectancy.1 Of 39 
million people estimated to be blind worldwide in 2010, 51% of cases were 
attributed to cataract.2 Regional variations in the prevalence and incidence of 
blindness and visual impairment (VI) due to age-related cataract exist, with a 
disproportionate prevalence in low and middle-income populations.  Africa is 
home to 11.9% of the global population, but 15% of the world’s blind, the 
majority of which is due to cataract.2 
 As no effective prevention strategies exist, management of cataract is 
principally surgical removal of the lens with simultaneous correction of 
aphakia. In SSA, extra-capsular cataract extraction (ECCE) is usually now 
performed, increasingly using a small-incision approach, although the use of 
phacoemulsification is rising. Cataract surgery constitutes one of the most 
cost-effective of all health interventions.3 Blindness and VI due to cataract is 
associated with reduced quality of life4 and visual function, which can be 
ameliorated following surgical management.5 Considerable social and 
economic disadvantages can result from cataract, especially in poor 
communities and contributes to the perpetual cycle of poverty.6 Indeed, 
provision of cataract surgery may be an effective tool in poverty alleviation.7 
Management of cataract is recognised as a priority of the VISION2020: The 
Right for Sight global strategy that targets avoidable blindness. 
 Knowledge of the epidemiology of cataract is crucial for eye care 
programmes in sub-Saharan Africa (SSA) to effectively plan public health eye 
care. Since the implementation of VISION2020, several population-based 
blindness surveys have been conducted globally to guide the implementation, 
development and extension of services, which include provision for cataract 
surgery. Moreover, newer rapid assessment methodologies have been 
developed and used including the rapid assessment of avoidable blindness 
(RAAB), an extension of the rapid assessment of cataract surgical services 
(RACSS).8 We aimed to determine the recent epidemiology of blindness and 
visual impairment (VI) due to cataract in SSA by investigating its prevalence 







Our literature search was conducted for the years 2000 – October 2012 using 
Medline, Embase and Google Scholar. Key words used included but were not 
limited to: cataract, lens opacity, visual impairment, low vision, blindness, 
presenting visual acuity, prevalence, and population.  All 48 SSA African 
countries as well as “Africa” and “sub-Saharan Africa” were used in the search 
terms. Studies were included if they were population-based with a sample 
size > 1000, reported presenting visual acuity (PVA) with its causes, had a 
high participation rate (>75%) and provided the standard WHO categories of 
visual acuity. We also searched reference lists of studies meeting inclusion 
criteria. Published studies, reported in English, French and Portuguese 
languages were included.   
 Where a population-based study of blindness had taken place more 
than once in a single country, data from the more recent survey (provided 
methodology was equivalent or superior) is presented, unless two separate 
geographical areas within the same country were sampled within five years of 
one another. Estimates from national surveys were used in preference to 
regional estimates from the same country. Both detailed population-based 
surveys and rapid assessment methods (RACSS and RAAB) were included. 
 Blindness was defined using WHO criteria as PVA in the better eye of 
<3/60 (<20/400; <1.30 LogMAR) while VI was defined as PVA in the better 
eye of <6/18-3/60 (<20/60-20/400; <0.48-1.30 LogMAR), representing the 
sum of moderate and severe VI. Thus, we did not investigate mild VI. All-
cause prevalence of blindness and VI were extracted from each study, as well 
as the proportion of blindness and VI due to cataract. Based on this 
information, the sample population prevalence of cataract blindness and 
cataract-related VI were computed using the denominator (number of persons 
examined), while the numerator was calculated using the proportion of 
blindness/VI due to cataract. We also extracted CSC (at PVA<3/60 and 
PVA<6/18 levels for persons), visual outcomes following cataract surgery and 
their causes [good (PVA>6/18), borderline (6/18 to 6/60) and poor 
(PVA<6/60)], and % IOL implantation. CSC was calculated as CSC=a/(a+c) 
[where a=aphakic or pseudophakic, c=cataract blindness or VI]. Lastly, we 
collected data on barriers to cataract surgery (unoperated subjects) and 
satisfaction with surgery (operated subjects).  
RESULTS 
Data from a total of 17 surveys from 15 different countries in SSA were 
included, encompassing 96,402 subjects who were examined (Table 1). Most 
studies examined only adults aged ≥40 or ≥50 years, however two studies 
included all ages, 9,10 and one ≥5 years. 11 There were two studies from 
Cameroon, representing one rural and one urban district.12,13 The only other 
country contributing two separate published studies was Tanzania, including 
RAAB surveys from Kilimanjaro and Zanzibar.14 15 Additional RAAB surveys 
were performed in Botswana 16, Burundi17, Malawi 18, Rwanda19, Eritrea20, and 
Kenya.21 Five studies were national surveys. 16,20,9,11,22  All studies employed 
cluster random sampling, with differences in the sampling used within cluster.  
 Blindness prevalence ranged from 0.4% in Uganda to 9.0% in  
Eritrea (Table 2). Only two studies - Eritrea and Ethiopia - had blindness 
prevalence estimates exceeding 5%.  Cataract accounted for between 21% of 
blindness in Cameroon and the highest proportion, 67%, was in Zanzibar, 
Tanzania. Cataract was the principal cause of blindness in 15 of 17 studies.  
 The prevalence of VI (sum of moderate and severe VI) ranged from 
1.6% in Gambia and Uganda to 17.1% in Ghana (Table 3). Cataract was the 
major cause of VI in 14 of 17 studies. The prevalence of VI due to cataract 
ranged from 18 to 87%.  
 CSC data were variable, and for blind persons ranged from 15% in 
Burundi to 80% in Limbe, Cameroon.  This included aphakia and 
pseudophakia; and for patients who had received cataract surgery, between 
62% and 100% had an IOL (Table 4). In terms of PVA, the proportion of good 
outcomes ranged from 23% to 70%.  Poor outcomes (VA<6/60) accounted for 
more than 20% in all studies and ranged from 23% to 64%. 
 There was a strong positive correlation between good visual outcomes 
and IOL use (R=0.69, P=0.027). There was an inverse correlation between 
IOL use and poor visual outcome (R=-0.31, P=0.384). [There was an inverse 
relationship between the proportion of blindness due to cataract and CSC 
(persons, blindness): R=-0.50, P=0.137. There was an inverse relationship 
between CSC (blind) and good visual outcome: R=-0.34, P=0.37]. 
 Causes of a poor visual outcome, barriers to cataract surgery and 
satisfaction rates with surgery were identified (Table 5). Insertion of an IOL is 
consistently associated with having a good visual outcome. Lack of 
awareness and inability to pay were frequently cited as major barriers to 
cataract surgery. The majority of individuals surveyed reported being satisfied 







We have provided an up-to-date review on blindness and VI due to cataract in 
SSA obtained from 17 studies of nearly 100,000 individuals. Wide differences 
in estimates of blindness and VI prevalence due to cataract were evident in 
this study, but cataract remains the principal cause of blindness in SSA. 
Although cataract prevalence is high in some Asian and South American 
populations it is on average lower than Africa and much lower in areas of 
higher HDI.23  
 Unsurprisingly, the population with the lowest blindness prevalence in 
this study, Uganda, has had a strong recent history of successful eye care 
programme delivery. The differences between countries are striking: a 74-fold 
difference in cataract blindness prevalence between Uganda and Mali who 
have similar GDP (Per-capita) of US$487 and US$669 respectively (World 
Bank 2011). Successful blindness prevention programme delivery and 
available cataract surgical services and human resources especially in rural 
areas, shorter distances and easier transport for patients, affordable fee 
structures or free services, and cultural barriers to service access may 
account for these huge differences. Further studies are required to quantify 
the resources required to make such differences, and to examine how this 
has been achieved. 
 It has been suggested that a cataract surgical rate (CSR) of ≥ 2,000 
operations/million population/year should be achieved annually to eliminate 
unnecessary blindness due to cataract in Africa.24 This benchmark is in stark 
contrast to the current situation in many parts of Africa, with over 80% of 
WHO member states in Africa having a CSR<1000.3 A substantial increase in 
CSR is needed to reduce blindness and VI due to cataract in SSA. Worse HDI 
ranks are associated with a higher prevalence of cataract blindness, and in 
SSA a much higher proportion of individuals undergoing surgery for cataract 
have pre-operative blindness or SVI compared to higher-income 
populations.25 The challenge remains reaching blind and visually impaired 
people by providing accessible, affordable, and sustainable cataract surgical 
services. 
Importantly, any increase in cataract surgical output is usually 
accompanied by an increase in outcome. The proportion of good 
outcomes ranged from 23% to 70%, all of which fail to reach the WHO 
target that ≥ 85% of eyes should achieve PVA<6/18 post-operatively. 
These proportion of good visual outcomes in most studies were 
markedy lower than from recent hospital-based studies on this 
continent.26 27 Prospective monitoring of outcomes can improve 
quality,28 with a dynamic and learning process for the surgeon of 
focusing on reducing surgical complications, greater emphasis on 
appropriate selection, need for spectacle correction, and sequelae of 
surgery. In many settings non-physician cataract surgeons provide the 
majority of cataract surgery. There remains controversy as to whether 
this cadre of surgeon is ideal to meeting the cataract surgical needs in 
SSA. Greater regulation and long-term training of physician-surgeons 
may provide a better long-term solution. 
Population-based data on visual outcomes is highly valuable as 
clinic/hospital based outcome estimates are not often representative of 
the visual status in the community. However, as modern techniques 
using ECCE with IOL implantation are now ubiquitous in almost all 
areas of SSA, population-based outcomes are likely to be worse as they 
may capture outcomes for surgeries performed up to many years prior 
(e.g. ICCE). Uncorrected aphakia remains an important contributor to 
blindness and VI in many areas of SSA.29 More recently performed 
cataract surgery is associated with more frequent use of lOLs2130, which 
in turn is positively correlated with a good visual outcome. In some 
areas, cataract removal by couching leading to aphakia is associated 
with extremely poor visual outcomes, even with aphakic correction.31  
Poor visual outcomes ranged from 23% to 64%, with the causes 
of poor outcomes being variable, and representing differences in 
expertise, resources and monitoring/surveillance. Understanding the 
causes of such poor outcomes is vital. Visual outcomes can be 
ameliorated with improved case selection and avoidance of surgery in 
patients who won’t benefit; improving the quality of surgery and avoiding 
surgical complications; improving the operative (IOL) and/or post-
operative correction of refractive error and; reducing late post-operative 
complications.32 Further cataract surgery outcomes data is needed from 
studies in SSA, and globally, to assess not only the importance and 
complexity of good outcomes and to revisit the parameters set by the 
WHO, but most importantly to understand and disseminate knowledge 
about how to improve outcomes.  
 
 It is intuitive that in order to reduce the blindness and VI due to cataract 
the CSR needs to exceed the cataract incidence rate. Lewallen et al. have 
modeled the incidence of vision-reducing cataract in Africa using data from 
RAAB surveys.33 Such derived estimates may assist further with the planning 
of services in this resource-poor region where incidence estimates are scarce, 
and have indicated disparities in cataract incidence in this continent. WHO 
recommends the establishment of ≥ one cataract unit per district of a million 
population in order to deal with cataract blindness and VI.3 CSR’s also reflect 
variations in genetic, environmental, or cultural factors and will vary with 
population structure, which is not uniform across Africa.33  
 Two indicators can measure the impact of initiatives to target cataract. 
Firstly, performing serial cross-sectional population-based surveys to 
demonstrate evidence of a reduction in prevalence of cataract (and blindness 
and VI due to cataract) over time.34 35 Another indicator is to measure the 
CSC which represents a ratio of the met and unmet need for cataract surgery, 
and is a measurement of the capability of a health care system to provide 
cataract surgical services to the population.36 In these studies, the CSC for 
persons for blinding cataract ranged from 22 to 70%, and was usually higher 
in men reflecting a probably gender inequity in access to cataract surgical 
services.37 CSR is positively correlated with CSC,25 but CSC does not take 
into account the quality of surgery provided.  
 There are several limitations to this review. Inter-study differences exist 
in relation to the size, age/gender composition, response rates and degree of 
urbanization as well as degree of government and non-government 
organization involvement in the surveyed areas. Such differences may 
account for some of the heterogeneity between individual results. RAAB 
surveys have several disadvantages including their lack of detailed cataract 
phenotype information.  Nonetheless, the validity of the RAAB compared to a 
more detailed survey is high.38  
 In conclusion, cataract is by far the most common cause of blindness 
and VI in SSA. Efforts to reduce the burden of blindness and VI due to 
cataract should incorporate high-volume, high-quality, affordable cataract 
surgery that greatly improves the CSR and CSC in such populations. This can 
be achieved by the implementation of well-run, cost-effective, and sustainable 
cataract units at the district level. Wide variation in the prevalence of cataract 
blindness has been shown in this review, and although this may be due to 
disparities in eye care programme delivery, it may also reflect inter-population 
differences in cataract incidence. The fundamental problems highlighted by 
this review are that currently too few cataract surgeries are being performed 
and there are too many poor outcomes.  An open and urgent appraisal of 
positive successes throughout SSA should be performed and shared. 
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Table 1. Population-based studies from sub-Saharan Africa with data on blindness and age-related cataract 
 
Country Level Year Published 
Sampling 
Method Sampling within cluster 
Sample size 





Botswana National 2009 CRS Compact segment sampling 2127 79.9 ≥50  16 
Burundi Provincial  2012 CRS Compact segment sampling 3684 97 ≥50  41 
Cameroon  Limbe 2007 CRS Compact segment sampling 2215 92.3 ≥40  12 
Cameroon  Muyuku 2006 CRS Random Walk 1787 89.3 ≥40  13 
Eritrea National 2011 CRS Compact segment sampling 3163 95.9 ≥50 
  
 20 
Ethiopia National 2007 CRS Random Walk 25650 85.4 All  9 
Gambia National 2000 CRS Compact segment sampling 13046 92 ≥5  11 
Ghana City 2012 CRS House to house census 5603 82.3 ≥40  42 
Guinea District, Bioko 2002 CRS Household cluster sampling 3218 NS All  10 
Kenya District, Nakuru 2007 CRS Compact segment sampling 3503 92.6 ≥50  21 
Malawi District 2011 CRS Compact segment sampling 3430 95.7 ≥50  18 
Mali Sub-national 2008 CRS Compact segment sampling 2438 NS ≥50  
Nigeria National 2009 CRS Random Walk 13599 89.9 ≥40  22 
Rwanda Western province 2007 CRS Compact segment sampling 2206 98 ≥50  19 
South Sudan District  2006 CRS Random Walk 2499 84.6 ≥5  43 
Tanzania 
(Kilimanjaro) Regional 2010 CRS Random Walk 3436 95.5 ≥50  14 
 Tanzania 
(Zanzibar) Island 2007 CRS Compact segment sampling 3160 98.8 ≥50  15 
Uganda 
15 neighbouring 
villages 2002  CRS NS  4076 98.9 ≥13  44 





Table 2. Prevalence and leading causes of blindness (PVA < 3/60 in worse eye) in sub-Saharan Africa 
 
Country Bilateral blindness 
prevalence (95% CI) 












Botswana 3.69 (2.4-5.0) Cataract 47 NS NS 1.7 16 
Burundi 1.1 (0.8-1.4) Cataract 55 PSED 37 0.6 41 
Cameroon (Limbe) 1.1 (0.7-1.5) PSED 29 Cataract  21 0.2 12 
Cameroon (Muyuka) 1.6 (0.8-2.4) Cataract 62 PSED & Onchocerciasis 14 1.0 13 
Eritrea 9.0 (8.0-10.0) Cataract 55 Glaucoma 15 5.0  
20
 
Ethiopia 7.9 (6.9-8.9) Cataract 50 Trachoma 20 4.0 9 
Gambia* 0.42 Cataract 45 Other corneal 16 0.2 11 
Ghana# 1.2 Cataract 44 Glaucoma 22 0.5 42 
Guinea 3.2 (2.6-3.9) Cataract 61 Macular affection  25 2.0 10 
Kenya 2.0 (1.5-2.4) Cataract 42 PSED 30 0.8 21 
Malawi 3.3 (2.5-4.1) Cataract 48 Glaucoma 16 1.6 18 
Mali 11.07 (9.55-12.6) Cataract 61 Surgical Complications 10 6.8  
Nigeria 4.2 (3.8-4.6) Cataract 43 Glaucoma 17 1.8 22 
Rwanda 1.8 (1.2-2.4) Cataract 65 PSED 20 1.2 19 
South Sudan 4.1 (3.4-4.8) Cataract 41 Trachoma 35 1.7 43 
Tanzania 
(Kilimanjaro) 
2.4 (1.9-2.9) Cataract 51 PSED 36 1.2 14 
Tanzania (Zanzibar) 3.7 Cataract 67 PSED  25 2.5 15 
Uganda 0.4 (0.3-0.7) Glaucoma 39 Cataract  23 0.1 44 
PSED: Posterior Segment Eye Disease; CI: Confidence Interval; NS- not stated 
* Estimates for ≥50 years 
# This study excludes refractive error from table of blindness/VI aetiology.  
 
 
 Table 3. Leading causes of Visual Impairment (VI) in sub-Saharan Africa 
 
Country Main cause of VI Proportion of VI (%) 2nd Main cause of VI Proportion of VI (%) Ref 
Botswana Cataract 59 NS NS  16 
Burundi Refractive Error  67 Cataract 18  41 
Cameroon (Limbe) Cataract 48 Refractive Error 22  12 
Cameroon (Muyuka) Cataract 40 PSED 28  13 
Eritrea Cataract 55 Refractive Error 31   
 20 
Ethiopia Cataract 34 Refractive Error 26  9 
Gambia Cataract 61 (≥ 50 years) Uncorrected aphakia 12 (≥50 years)  11 
Ghana* Cataract 53* Glaucoma  14*  42 
Guinea Cataract 87 Macular affection 29  10 
Kenya Cataract 36 Refractive Error 32  21 
Malawi Cataract 46 Refractive Error 41  18 
Mali Cataract 61 Refractive Error 22  
Nigeria Refractive Error  57 Cataract 26  22 
Rwanda Cataract 55 Refractive Error 30  19 
South Sudan Trachoma 58 Cataract  29  43 
Tanzania (Kilimanjaro) Cataract 55 Refractive Error 33  14 
Tanzania (Zanzibar) Cataract 47 Refractive Error 39  15 
Uganda Cataract 57 Refractive Error  19  44 
PSED: Posterior Segment Eye Disease; VI- Visual Impairment; NS- not stated 
VI 6/18 to 3/60 





Table 4. Cataract Surgical Coverage, Visual outcomes following cataract surgery, and %IOL use in sub-Saharan Africa 
 
Country CSC (VA<6/18) persons CSC (blind persons [PVA<3/60]) Visual outcome (PVA) IOL  




Males Females Total  
persons 




Botswana 53 62 48 62 73 55 NS NS NS 
Burundi 12 9 13 22 17 24 70 30 100 
Cameroon (Limbe) NS NS NS 80 NS NS 23 58 69 
Cameroon (Muyuka) NS NS NS 55 NS NS 25 64 68 
Eritrea 48 50 46 68 71 65 41 39 75 
Kenya 51 51 51 78 78 78 50 31 58 
Malawi 16 25 10 45 62 30 41 32 68 
Mali 34 39 30 59 70 51 28 58 33 
Nigeria NS NS NS NS NS NS 30 41 40 
Rwanda 21 24 19 47 64 36 24 41 62 
Tanzania 
(Kilimanjaro) 
42 48 37 70 73 67 59 23 87 
Tanzania (Zanzibar) 20 25 17 60 77 49 32 38 68 
 
CSC- cataract surgical coverage; NS- not stated; PVA- presenting visual acuity; IOL- intraocular lens 
No data was available from Ethiopia, Ghana, Guinea, South Sudan and Uganda 
 
 
Table 5: Causes of poor outcome and barriers to cataract surgery in studies with available data in sub-Saharan Africa 











   
Cameroon (Limbe) NS 
Aphakia (compared to IOL use). 
Older age.  
Inability to pay (40%), lack of 
awareness (17%), a feeling they 
could cope with the cataract (10%) 
and that they were waiting for 
cataract to mature (8%). 
NS 
Cameroon (Muyuka) NS 
Aphakia (compared to IOL use). 
Older age.  
Lack of awareness of cataract 
(33.3%), inability to pay (30.1%), 
and a feeling they could cope with 
the cataract (9.6%). 
NS 
Eritrea 27% 24% 48% 
Having surgery performed at a 
voluntary or charitable hospital 
compared to a government hospital  
30% reported “Cannot afford”, 
followed by “Waiting for maturity” 
(18%), “No company” (17%), 
“Contra-indication” (12%) and “Old 
age, no need” (10%). 
NS 
Kenya 36% 30% 34%  Not specified for poor outcome.  
However, good outcome was more 
likely if the surgery was with an IOL, 
performed in last 5 years or 
undertaken in a volunteer/charity 
hospital or private hospital rather than 
government hospital or eye camp  
 “Not aware of surgery” (34.1%), 
“cannot afford the operation” 
(24.4%), and “no one to take me” 
(12.2%). 
 
64% were very satisfied, 
19% were somewhat 
satisfied, 5% were 
indifferent, and 12% were 
somewhat or very 
dissatisfied. 
Malawi 40% 47% 13% 
NS Old age (‘no need felt’) was 
reported to be the commonest 
barrier (23.5%) followed by ‘no 
one to accompany’ (22.1%), ‘no 
services nearby’ (13.2) and 
‘unaware that treatment was 
available’ (11.8%). 
84.8% of all persons who 
had surgery were either 
very satisfied or partially 
satisfied. Only 3% of 
persons were very 
unsatisfied with the results 
of surgery. 
Nigeria 
NB: Barriers refers to 
Abubakar et al. 
Coverage of Hospital-
based Cataract 
Surgery and Barriers 







In multivariate analysis of data on 
first-operated eyes, the only variable 
associated with poor outcome (<6/60 
at presentation) was non-IOL surgery. 
 
Cost of surgery (over a third),  
other personal factors (a quarter), 
and another quarter cited barriers 
such as being too old, not knowing 
where to go and fear of surgery. 
Provider-related factors, such as 
being told to attend later, were 
reported by 9.8%. 
There were significant rural/urban 
NS 
This refers to: Imam et al. Outcome of Cataract 
Surgery in Nigeria: 
Visual Acuity, Autorefraction, and Optimal 
Blind Persons in 
Nigeria:  
Intraocular Lens Powers—Results from the 
Nigeria National Survey 
differences in cost as a barrier. 
Rwanda 25% 50% 25% 
NS 
Lack of awareness of the 
availability of treatment (52%), 
followed by a perceived lack of 
services (16%), inability to afford 
the surgery (16%), and lack of a 
companion (8%). 
41% were very satisfied, 
28% were partially 
satisfied, indifferent (7%), 
partially dissatisfied (17%), 
or very dissatisfied (7%). 
Tanzania 
(Kilimanjaro) 
31%  38% 25% Eyes with an IOL had significantly 
better vision than eyes without 
NS NS 
Tanzania (Zanzibar) 
The major cause of poor outcome for operations 
>3yrs ago was selection and presently it is due to 
sequale. 
Surgery was a major cause for poor outcome for both 
time periods.  
NS 
Unaware of treatment (30%), 
waiting for cataract to mature 
(20%) and cost (10%). 
56% very satisfied, 25.9% 
partially satisfied,  7.9% 
very dissatisfied 
 
Key- NS- not stated; URE- uncorrected refractive error 
 
